Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-21

Clinical Trial Update: Vizol S Lipid Balance Efficacy and Safety Study in Patients With Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 trial update for Vizol S assessing efficacy and safety in dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vizol S

Snippet

Sponsor: Jadran Galenski laboratorij d.d. | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED